TREA

79036313 - CERVIDX

Follow

Information

  • Trademark
  • 79036313
  • Serial Number
    79036313
  • Registration Number
    3476787
  • Filing Date
    September 20, 2006
    17 years ago
  • Registration Date
    July 29, 2008
    16 years ago
  • Transaction Date
    September 21, 2018
    5 years ago
  • Status Date
    September 21, 2016
    7 years ago
  • Published for Opposition Date
    February 05, 2008
    16 years ago
  • Location Date
    July 29, 2008
    16 years ago
  • Status Code
    404
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BRODY, DANIEL S
  • Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
CERVIDX
Case File Statements
  • GS0011: Chemical preparations and reagents for detection of cancerous conditions, neoplastic conditions, inflammatory conditions, infectious conditions, degenerative conditions, genetically aberrant or diseased conditions, proliferatively aberrant or diseased conditions, vascular disease conditions, premalignant cancerous conditions, malignant cancerous conditions, cancer and inborn deficiencies for scientific or research use
  • GS0051: Pharmaceutical preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn deficiencies; veterinary preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous, conditions, cancer and inborn deficiencies in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds; medical diagnostic reagents for detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the detection of premalignant and malignant cancerous conditions, cancer and inborn deficiencies; medical diagnostic preparations, namely, in-vitro and in-vivo diagnostic preparations, diagnostic immunocytochemical preparations, diagnostic immunohistochemical preparations, diagnostic histology preparations, diagnostic cytology preparations, diagnostic liquid-immuno-assay preparations, diagnostic solid-phase immuno-assay preparations, diagnostic testing strips, diagnostic dip-stick tests, diagnostic preparations for use at point of care, diagnostic lateral-flow assay preparations, diagnostic flow-through assay preparations, diagnostic immuno-chromatographic preparations; diagnostic equipment for medical purposes, namely, strips, cotton sticks, swabs, cotton and tampons for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies as indicated above
  • GS0091: Laboratory equipment for diagnostic purposes, namely, test tubes, multiwell test plates, multiwell ELISA (enzyme linked immunosorbent assay) plates and chromatography columns for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating biological material and samples
  • GS0101: Medical diagnostic testing machines, namely, point-of-care testing machines, diagnostic liquid-immuno-assay machines, diagnostic immunocytochemical machines, diagnostic immunohistochemical machines, diagnostic histology machines, diagnostic cytology machines, diagnostic solid-phase immuno-assay machines, diagnostic ELISA (enzyme linked immunosorbent assay) testing machines, diagnostic immuno-chromatographic machines, all of the aforementioned machines being for use in analyzing and providing diagnostic test results and used in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; diagnostic equipment for medical purposes, namely, syringes, needles, brushes, spatulas and sample receptacles for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; diagnostic nucleic acid detection machines for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; diagnostic nucleic acid amplification machines for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; diagnostic immuno-histology machines for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; diagnostic immuno-cytology machines for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; medical diagnostic apparatus and instruments, namely, hand-held, table-top and floor-standing centrifugal, gravitational-separating, electrophoretic, chromatographic, conductometric, potentiometric, spectrometric, spectro-photometric, radiologic electromagnetic-resonance, histological, microscopic and in-vivo imaging machines, all for for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; automated and non-automated cellular imaging devices for medical use for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies, automated and non-automated microscopy devices for medical use for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies, automated and non-automated imaging analysis devices for clinical and medical laboratory use for use in preparing, enriching, concentrating, testing, analysing and evaluating of biological material and samples in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies
  • GS0421: Scientific analysis in the fields of chemistry, biology and molecular biology; laboratory research in the field of molecular biology; laboratory research in the fields of pharmaceutics and food technology; providing research in the fields of pharmaceutical, chemical and medical diagnostic research; research and development of pharmaceutical products and substances for others; scientific research in the nature of scientific information research services; chemical, biological, molecular biology and pharmacogenomic analysis services
  • GS0441: Medical diagnostic services and provision of medical diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds
Case File Event Statements
  • 9/20/2018 - 5 years ago
    36 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED Type: DENC
  • 9/20/2018 - 5 years ago
    35 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH
  • 2/5/2016 - 8 years ago
    34 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT
  • 1/14/2016 - 8 years ago
    33 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS
  • 1/14/2016 - 8 years ago
    32 - INVALIDATION PROCESSED Type: INPC
  • 11/6/2015 - 8 years ago
    31 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR
  • 3/6/2015 - 9 years ago
    30 - CANCELLED SECTION 71 Type: C71T
  • 12/30/2012 - 11 years ago
    29 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 3/2/2012 - 12 years ago
    28 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 11/17/2008 - 15 years ago
    27 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 11/17/2008 - 15 years ago
    26 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 10/29/2008 - 15 years ago
    25 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 7/29/2008 - 16 years ago
    24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/20/2008 - 16 years ago
    23 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP
  • 2/13/2008 - 16 years ago
    22 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 2/5/2008 - 16 years ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/16/2008 - 16 years ago
    20 - NOTICE OF PUBLICATION Type: NPUB
  • 1/3/2008 - 16 years ago
    19 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 1/3/2008 - 16 years ago
    18 - ASSIGNED TO LIE Type: ALIE
  • 11/15/2007 - 16 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/15/2007 - 16 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 11/15/2007 - 16 years ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 11/15/2007 - 16 years ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 11/15/2007 - 16 years ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 11/15/2007 - 16 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/13/2007 - 16 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/13/2007 - 16 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/13/2007 - 16 years ago
    9 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 6/1/2007 - 17 years ago
    8 - REFUSAL PROCESSED BY IB Type: RFNP
  • 5/11/2007 - 17 years ago
    7 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 5/11/2007 - 17 years ago
    6 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 5/3/2007 - 17 years ago
    5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 5/2/2007 - 17 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/27/2007 - 17 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/27/2007 - 17 years ago
    2 - NEW APPLICATION ENTERED IN TRAM Type: NWAP
  • 4/26/2007 - 17 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR